Read more

April 22, 2022
2 min watch
Save

VIDEO: Ocular surface disease treatment becoming essential in refractive cataract surgery

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Adam Szaronos, CEO of TearLab, discusses the intersection of ocular surface disease treatment and refractive cataract surgery.